1. Unilateral acute posterior multifocal placoid pigment epitheliopathy in a convalescent COVID-19 patient
- Author
-
Linda Cernichiaro-Espinosa, Arturo Olguín-Manríquez, Francisco Olguin-Manriquez, Rebeca Manríquez-Arias, Perla Ayumi Kawakami-Campos, and Erick Omar Flores-Villalobos
- Subjects
medicine.medical_specialty ,Acute posterior multifocal placoid pigment epitheliopathy ,Ophthalmic examination ,Coronavirus disease 2019 (COVID-19) ,Coronavirus disease 2019 ,business.industry ,Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ,Case Report ,Case presentation ,RE1-994 ,Dermatology ,Low vision ,03 medical and health sciences ,Ophthalmology ,0302 clinical medicine ,Female patient ,030221 ophthalmology & optometry ,medicine ,Severe acute respiratory syndrome coronavirus 2 ,In patient ,030212 general & internal medicine ,business - Abstract
Background To report a case of unilateral acute posterior multifocal placoid pigment epitheliopathy (APMPPE) in a Hispanic convalescent COVID-19 female patient. Case presentation A 35-year-old Hispanic female with exposure to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was evaluated due to unilateral visual loss. Ophthalmic examination and diagnostic tests were consistent with APMPPE. Discussion Ocular changes can be observed in patients with COVID-19. A complete ophthalmic evaluation must be performed in patients with low vision after SARS-CoV-2 infection.
- Published
- 2021